Literature DB >> 3157380

Cystathionine beta synthase: gene dosage effect in trisomy 21.

B Chadefaux, M O Rethoré, O Raoul, I Ceballos, M Poissonnier, S Gilgenkranz, D Allard.   

Abstract

The enzymatic activity of cystathionine beta synthase has been studied in fibroblasts of nine patients with regular trisomy 21. An excess of CBS activity was found in trisomy 21 with a trisomy 21/normal ratio equal to 1.66. A 1.04 ratio was found in 21q21----21 p ter monosomy; a 1.04 and 0.99 ratio was found in two 21 qter----21q22.3 monosomies; a 1.14 ratio in 21 qter----21q22 monosomy; a 0.89 ratio in a 21q21----21 pter trisomy; an excess of CBS activity was found in a 21q22.1 ----21q21 trisomy with a 1.57 ratio. These results show a gene dosage effect in human fibroblasts trisomic for chromosome 21 and suggest the assignment of human CBS locus between 21q22.1 and 21q21.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157380     DOI: 10.1016/0006-291x(85)91641-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Homocysteine and the methotrexate toxicity in trisomy 21.

Authors:  J Lejeune; M Peeters; M O Rethore; M C de Blois
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 3.  Interactions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology.

Authors:  Mayumi Kajimura; Ryo Fukuda; Ryon M Bateman; Takehiro Yamamoto; Makoto Suematsu
Journal:  Antioxid Redox Signal       Date:  2010-07-15       Impact factor: 8.401

4.  Methotrexate sensitivity in Down's syndrome: a hypothesis.

Authors:  P M Ueland; H Refsum; B Christensen
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Homocysteinaemia and coronary atherosclerosis.

Authors:  T O Cheng
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

6.  Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids.

Authors:  M L Van Keuren; P C Watkins; H A Drabkin; E W Jabs; J F Gusella; D Patterson
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

7.  Alterations in the Serotonin and Dopamine Pathways by Cystathionine Beta Synthase Overexpression in Murine Brain.

Authors:  J London; F K Ndiaye; L C Bui; B Souchet; F Daubigney; C Magnan; S Luquet; J Dairou; N Janel; C Rouch
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

Review 8.  Reactive nitrogen species and hydrogen sulfide as regulators of protein tyrosine phosphatase activity.

Authors:  Petr Heneberg
Journal:  Antioxid Redox Signal       Date:  2014-03-11       Impact factor: 8.401

9.  Plasma amino acids and neopterin in healthy persons with Down's syndrome.

Authors:  A W Coppus; D Fekkes; W M A Verhoeven; S Tuinier; J I M Egger; C M van Duijn
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

10.  A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21.

Authors:  Kenichi Miyamoto; Nobutaka Suzuki; Kosuke Sakai; Shuichi Asakawa; Tsuneko Okazaki; Jun Kudoh; Masashi Ikeno; Nobuyoshi Shimizu
Journal:  Transgenic Res       Date:  2013-11-30       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.